Phase I study of corynebacterium parvum in patients with solid tumors. 1975

P R Band, and C Jao-King, and R C Urtasun, and M Haraphongse

Nineteen patients with various solid tumors were treated with Corynebacterium parvum for 10 consecutive days at doses ranging from 0.5 to 6 mg/m2. Major toxic effects included rigors and cyanosis, hypertension, headache, nausea, and vomiting. Toxicity was maximal during the first 3 days of treatment and decreased or even disappeared when, on subsequent days, increasing doses of the vaccine were given. Objective tumor regressions were observed in four patients.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009362 Neoplasm Metastasis The transfer of a neoplasm from one organ or part of the body to another remote from the primary site. Metastase,Metastasis,Metastases, Neoplasm,Metastasis, Neoplasm,Neoplasm Metastases,Metastases
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D011425 Propionibacterium acnes A bacteria isolated from normal skin, intestinal contents, wounds, blood, pus, and soft tissue abscesses. It is a common contaminant of clinical specimens, presumably from the skin of patients or attendants. Corynebacterium acnes,Corynebacterium parvum
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

P R Band, and C Jao-King, and R C Urtasun, and M Haraphongse
September 1979, Minnesota medicine,
P R Band, and C Jao-King, and R C Urtasun, and M Haraphongse
July 1976, Cancer,
P R Band, and C Jao-King, and R C Urtasun, and M Haraphongse
April 1976, Cancer,
P R Band, and C Jao-King, and R C Urtasun, and M Haraphongse
January 1977, Developments in biological standardization,
P R Band, and C Jao-King, and R C Urtasun, and M Haraphongse
May 1979, Cancer,
P R Band, and C Jao-King, and R C Urtasun, and M Haraphongse
February 2023, Signal transduction and targeted therapy,
P R Band, and C Jao-King, and R C Urtasun, and M Haraphongse
October 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
P R Band, and C Jao-King, and R C Urtasun, and M Haraphongse
June 2016, American journal of clinical oncology,
P R Band, and C Jao-King, and R C Urtasun, and M Haraphongse
February 1994, Anti-cancer drugs,
P R Band, and C Jao-King, and R C Urtasun, and M Haraphongse
February 2002, Journal of pediatric hematology/oncology,
Copied contents to your clipboard!